Citation: R. Hausmann et al., PERFORMANCE ENHANCING DRUGS (DOPING AGENTS) AND SUDDEN-DEATH - A CASE-REPORT AND REVIEW OF THE LITERATURE, International journal of legal medicine, 111(5), 1998, pp. 261-264
Authors:
CAVACINI LA
SAMORE MH
GAMBERTOGLIO J
JACKSON B
DUVAL M
WISNEWSKI A
HAMMER S
KOZIEL C
TRAPNELL C
POSNER MR
Citation: La. Cavacini et al., PHASE-I STUDY OF A HUMAN MONOCLONAL-ANTIBODY DIRECTED AGAINST THE CD4-BINDING SITE OF HIV TYPE-1 GLYCOPROTEIN-120, AIDS research and human retroviruses, 14(7), 1998, pp. 545-550
Authors:
KASTRISSIOS H
SUAREZ JR
HAMMER S
KATZENSTEIN D
BLASCHKE TF
Citation: H. Kastrissios et al., THE EXTENT OF NONADHERENCE IN A LARGE AIDS CLINICAL-TRIAL USING PLASMA DIDEOXYNUCLEOSIDE CONCENTRATIONS AS A MARKER, AIDS, 12(17), 1998, pp. 2305-2311
Authors:
LALLEMANT M
MCINTOSH K
JOURDAIN G
LECOEUR S
VITHAYASAI V
LEE TH
HAMMER S
PRESCOTT N
ESSEX M
Citation: M. Lallemant et al., ETHICS OF PLACEBO-CONTROLLED TRIALS OF ZIDOVUDINE TO PREVENT THE PERINATAL TRANSMISSION OF HIV IN THE THIRD-WORLD, The New England journal of medicine, 338(12), 1998, pp. 839-840
Citation: P. Gilbert et al., EFFICIENT TRIAL DESIGNS FOR STUDYING COMBINATION ANTIRETROVIRAL TREATMENTS IN PATIENTS WITH VARIOUS RESISTANCE PROFILES, The Journal of infectious diseases, 178(2), 1998, pp. 340-348
Authors:
ZACKIN R
MARSCHNER I
ANDERSEN J
COWLES MK
DEGRUTTOLA V
HAMMER S
FISCHL M
COTTON D
Citation: R. Zackin et al., PERSPECTIVE - HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA END-POINTS IN HIV CLINICAL-TRIALS - ISSUES IN INTERIM MONITORING AND EARLY STOPPING, The Journal of infectious diseases, 177(3), 1998, pp. 761-765
Citation: Sks. Smith et al., STUDYING PSEUDOSCIENCE AND LYING WITH STATISTICS TO ILLUSTRATE SCIENTIFIC ARGUMENTATION, Molecular biology of the cell, 8, 1997, pp. 2655-2655
Authors:
FALAGAS ME
SNYDMAN DR
GRIFFITH J
WERNER BG
FREEMAN R
ROHRER R
FAIRCHILD R
FAWAZ K
HOFFMAN MA
KAPLAN M
GILL M
RUBIN RH
DIENSTAG JL
DORAN M
OROURKE E
VACANTI J
JENKINS R
LEWIS WD
HAMMER S
MARTIN M
GRADY GF
LESZCZYNSKI J
DOUGHERTY N
KATZ A
FAUSETT G
PLATT R
CHEESEMAN SH
PASTERNACK M
GORBACH SL
Citation: Me. Falagas et al., CLINICAL AND EPIDEMIOLOGIC PREDICTORS OF RECURRENT CYTOMEGALOVIRUS DISEASE IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 25(2), 1997, pp. 314-317
Authors:
FALAGAS ME
SNYDMAN DR
RUTHAZER R
WERNER BG
GRIFFITH J
ROHRER R
FREEMAN R
FAWAZ K
HOFFMAN MA
KAPLAN M
GILL M
RUBIN RH
DIENSTAG JL
DORAN M
OROURKE E
VACANTI J
JENKINS R
LEWIS WD
HAMMER S
MARTIN M
FAIRCHILD R
WERNER BG
GRADY GF
LESZCZYNSKI J
DOUGHERTY N
KATZ A
FAUSETT G
PLATT R
CHEESEMAN SH
PASTERNACK M
GORBACH SL
Citation: Me. Falagas et al., SURVEILLANCE CULTURES OF BLOOD, URINE, AND THROAT SPECIMENS ARE NOT VALUABLE FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 24(5), 1997, pp. 824-829
Authors:
LENDERKING WR
TESTA MA
KATZENSTEIN D
HAMMER S
Citation: Wr. Lenderking et al., MEASURING QUALITY-OF-LIFE IN EARLY HIV DISEASE - THE MODULAR APPROACH, Quality of life research, 6(6), 1997, pp. 515-530
Authors:
ARENS M
MEYER W
BRAMBILLA D
BREMER J
FISCUS S
GRIFFITH B
HAMMER S
HODINKA R
KABAT W
YENLIEBERMAN B
MYERS L
REICHELDERFER P
Citation: M. Arens et al., STABILITIES OF FREE AND COMPLEXED HUMAN-IMMUNODEFICIENCY-VIRUS P24 ANTIGENS DURING SHORT-AND LONG-TERM STORAGE, Journal of clinical microbiology, 35(9), 1997, pp. 2413-2416
Citation: S. Hammer et al., INDICATION OF INFLAMMATION AND CELL-DAMAGE BY ENHANCED RELEASE OF MEMBRANE PHOSPHOLIPIDS (PLS), Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 173-173
Authors:
GRIESBACHER T
SAMETZ W
LEGAT FJ
DIETHART S
HAMMER S
JUAN H
Citation: T. Griesbacher et al., EFFECTS OF THE NONPEPTIDE B-2 ANTAGONIST FR173657 ON KININ-INDUCED SMOOTH-MUSCLE CONTRACTION AND RELAXATION, VASOCONSTRICTION AND PROSTAGLANDIN RELEASE, British Journal of Pharmacology, 121(3), 1997, pp. 469-476
Authors:
FALAGAS ME
SYNDMAN DR
GRIFFITH J
RUTHAZER R
WERNER BG
ROHRER R
FREEMAN R
FAIRCHILD R
FAWAZ K
HOFFMAN MA
KAPLAN M
GILL M
RUBIN RH
DIENSTAG JL
DORAN M
OROURKE E
VACANTI J
JENKINS R
LEWIS WD
HAMMER S
MARTIN M
GRADY GF
LESZCZYNSKI J
DOUGHERTY N
KATZ A
FAUSETT G
PLATT R
CHEESEMAN SH
PASTERNACK M
GORBACH SL
Citation: Me. Falagas et al., EFFECT OF CYTOMEGALOVIRUS-INFECTION STATUS ON FIRST-YEAR MORTALITY-RATES AMONG ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Annals of internal medicine, 126(4), 1997, pp. 275
Citation: E. Coakley et al., SERUM HIV-1 RNA AS A PREDICTOR OF SURVIVAL IN HIV-INFECTED INDIVIDUALS WITH CD4 CELL COUNTS LESS-THAN-OR-EQUAL-TO 50 MM(3)/, Clinical infectious diseases, 23(4), 1996, pp. 255-255
Authors:
FALAGAS ME
SNYDMAN DR
GRIFFITH J
WERNER BG
ROHRER R
FREEMAN R
FAWAZ K
HOFFMAN MA
KAPLAN M
GILL M
RUBIN RH
DIENSTAG JL
DORAN M
OROURKE E
VACANTI J
JENKINS R
LEWIS WD
HAMMER S
MARTIN M
FAIRCHILD R
GRADY GF
LESZCZYNSKI J
DOUGHERTY N
KATZ A
FAUSETT G
PLATT R
CHEESEMAN SH
PASTERNACK M
GORBACH SL
Citation: Me. Falagas et al., EXPOSURE TO CYTOMEGALOVIRUS FROM THE DONATED ORGAN IS A RISK FACTOR FOR BACTEREMIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 23(3), 1996, pp. 468-474
Authors:
FALAGAS ME
SNYDMAN DR
RUTHAZER R
GRIFFITH J
WERNER BG
ROHRER R
FREEMAN R
FAWAZ K
HOFFMAN MA
KAPLAN M
GILL M
RUBIN RH
DIENSTAG JL
DORAN M
OROURKE E
VACANTI J
JENKINS R
LEWIS D
HAMMER S
MARTIN M
FAIRCHILD R
GRADY GF
LESZCZYNSKI J
DOUGHERTY N
KATZ A
FAUSETT G
PLATT R
CHEESEMAN SH
PASTERNACK M
GORBACH SL
Citation: Me. Falagas et al., PRIMARY CYTOMEGALOVIRUS-INFECTION IN LIVER-TRANSPLANT RECIPIENTS - COMPARISON OF INFECTIONS TRANSMITTED VIA DONOR ORGANS AND VIA TRANSFUSIONS, Clinical infectious diseases, 23(2), 1996, pp. 292-297
Authors:
LUNDHANSSEN H
GANNON J
ENGEBRETSEN L
HOLEN K
HAMMER S
Citation: H. Lundhanssen et al., ISOKINETIC MUSCLE PERFORMANCE IN HEALTHY FEMALE HANDBALL PLAYERS AND PLAYERS WITH A UNILATERAL ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION, Scandinavian journal of medicine & science in sports, 6(3), 1996, pp. 172-175
Citation: J. Gaube et al., A NEW EQUILIBRIUM CELL WITH VARIABLE CELL-VOLUME FOR STATIC VAPOR-PRESSURE MEASUREMENTS, Fluid phase equilibria, 123(1-2), 1996, pp. 245-257